• Welcome

  • Welcome to the Abstract Submission Website for
    the MACULART Meeting 2025
     
    Important dates
    October 14, 2024 - Opening of Abstract Submission
    Deccember 9, 2024 - Opening of Clinical Case Submission

    April, 16, 2025 - Deadline for Abstract Submission and Clinical Case Submission
     May 12, 2025 - Result Annoucement
    Mid-May, 2025 - Opening of a second phase of "Late breaking news" submissions
     
    Getting started
    It is simple to set up your personal account and submit your abstract!
    First of all, click on the button below marked 'Click here for your first connexion' and follow the steps:
    1- Enter your email address. It will be used to log into your personal account each time you visit the website. 
    2- Create your password. Your password should be easy for you to remember, something personal and at least 8 characters long. 
    3- Enter your personal information. All boxes with * are mandatory information and you will not be able to save your details unless these are completed.

    A summary of your account information will appear on the screen. To finalise the procedure, please be sure to click on 'Create Account', otherwise your information will not be saved.

    Please remember your login name and password! You will need them later to log into the system after a decision has been made for your abstract.
    Information will be sent only to the « contact author », to the e-mail address registered on login. This is why we recommend you provide the contact details of the presenting author when creating your author account.
     
    Submission guidelines
    Before submitting your abstract, thank you for paying attention to the following guidelines:

    => Your abstract must be submitted in ENGLISH and not exceed 300 words

    => It will have to be allocated to a specific category:
    • Prevention of AMD
    • Fibrosis
    • AI & Retina
    • Geography Atrophy
    • Macula Imaging
    • Neovascular AMD
    • Diabetes
    • Macular Surgery
    • Vein Occlusion
    • New therapeutic approaches
    • Gene Therapy
    • Myopia / Uveitis

    => The abstract must respect the following framework:
    • Objective
    • Material & Methods
    • Results
    • Conclusions

    => Simple tables, graphs and pictures are allowed.
     
    In order to avoid problems of incompatibility, we ask you to prepare your text with the Arial font, size 10. The text must be single space and a single paragraph starting without any indentation.

    Then, you will have to copy and paste the text (without the title and the list of authors) in the indicated field for this purpose using the appropriate icon .

    Title and author’s names will have to be typed out in separate fields.
      
    Publication
    All accepted abstracts will be published in the framework of the congress on the website.

    The Contributor guarantees that the content of his /her Contribution is compliant with the law and does not breach any rights of third parties (such as copyrights, images, obligation of confidentiality notably), either because he/she is the owner of the rights on all the components included in his/her Contribution, or because these components are free of any rights, or because he/she has obtained the express authorization of the relevant third parties.
    The Contributor undertakes to ensure with the utmost care the accuracy of the information he/she provides.
    The Contributor alone shall be the liable for the content of his/her Contribution and undertakes to guarantee Europa should the liability of Europa come to be incurred by a third party because of the content of the Contribution.


    When including pictures in your presentation, please beware when sourcing them from internet. They are generally not free of rights and can expose you to financial penalties (€1,500 per image) from their authors.
     
     Modifications
    You can modify your abstract until the submission deadline.
    No changes to the abstract will be possible once the submission deadline has passed.
    If necessary send an e-mail to: support-maculart@europa-organisation.com
     
     Selection process
    Abstracts will be considered for oral presentation or poster presentation.
    Results will be sent by email to the author who submitted the abstract.
     
     Registration
    The acceptance of an abstract does not mean free-of-charge participation. Registration, travel and accommodation will remain at the charge of abstract presenters.

    You will find more information directly on the congress website:
    https://www.maculart.fr

    For any questions about your registration, please contact our registration department:
    maculart@europa-organisation.com
     
     Any questions?
  • Login

    Email address
    Password
    Remember me
  • CALL FOR submissions
    technical support


    19 Allées Jean Jaurès - BP 61508
    31015 Toulouse Cedex 6 / France
    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to EUROPA ORGANISATION 19 allées Jean Jaurès BP 61508 31015 Toulouse Cedex 6 / France, to access your file in order to consult, modify and/or delete your personal information.

    © 2024 Europa Organisation